Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CK2 and PML: regulating the regulator.

Valérie Lallemand-Breitenbach1, Hugues de Thé

  • 1Université de Paris 7, CNRS, UMR 7151, Hôpital St. Louis, 75475 Paris Cedex 10, France.

Cell
|July 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pml loss worsens NEK1-linked ALS and Pml induction drives NEK1 degradation, precluding disease onset.

The FEBS journal·2026
Same author

The Znf711-Phf8 complex functions as a transcriptional rheostat essential for neutrophil development.

Haematologica·2026
Same author

Immune intervention is dispensable for retinoic acid/ arsenic therapy of murine acute promyelocytic leukemia.

Haematologica·2025
Same author

Retinoic acid disrupts an NPM1c/ROS/SENP3/ARF oncogenic axis in acute myeloid leukemia.

Leukemia·2025
Same author

[Pierre Tiollais (1934-2024), a pioneer in genetic engineering with a lifelong commitment to the hepatitis B virus].

Medecine sciences : M/S·2025
Same author

Biographical Feature: In memoriam Pierre Tiollais (1934-2024).

Journal of virology·2025

The promyelocytic leukemia (PML) protein prevents cancer. Phosphorylation by the CK2 kinase causes PML protein loss, promoting tumor growth. Inhibiting CK2 may prevent cancer development.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • The promyelocytic leukemia (PML) protein is a tumor suppressor that induces cellular senescence.
  • Loss of PML protein function is linked to cellular transformation and tumor progression under oncogenic stress.

Purpose of the Study:

  • To investigate the regulatory mechanisms controlling PML protein stability.
  • To determine the role of the CK2 kinase in PML protein degradation and its implications in cancer.

Main Methods:

  • Western blotting to assess protein levels.
  • Kinase assays to study PML phosphorylation by CK2.
  • Cellular senescence assays.

Main Results:

  • Phosphorylation of PML by CK2 leads to its degradation.

Related Experiment Videos

  • CK2 kinase activity is frequently elevated in human cancers.
  • Inhibition of CK2-induced PML degradation may counteract tumor formation.

    • Conclusions:

    • CK2-mediated phosphorylation and subsequent degradation of PML is a critical step in oncogenic transformation.
    • Targeting CK2 offers a potential therapeutic strategy to restore PML function and prevent cancer establishment.